Why and when should we cluster randomize?
Journal of Epidemiology and Population Health · 2024
DOI: 10.1016/j.jeph.2024.202197 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Epidemiology and Population Health, 2024. Verfasst von Bruno Giraudeau und 4 weiteren Autor:innen. Beteiligte Einrichtung: Université de Tours, Université de Nantes, INSERM, SPHERE U1246, Tours, France; INSERM CIC1415, CHRU de Tours, Tours, France. Electronic address: bru…. Hauptthemen laut MEDLINE: Research Design, Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
A cluster randomized trial is defined as a randomized trial in which intact social units of individuals are randomized rather than individuals themselves. Outcomes are observed on individual participants within clusters (such as patients). Such a design allows assessing interventions targeting cluster-level participants (such as physicians), individual participants or both. Indeed, many interventions assessed in cluster randomized trials are actually complex ones, with distinct components targeting different levels. For a cluster-level intervention, cluster randomization is an obvious choice: the intervention is not divisible at the individual-level. For individual-level interventions, cluster randomization may nevertheless be suitable to prevent group contamination, for logistical reasons, to enhance participants' adherence, or when objectives pertain to the cluster level. An unacceptable reason for cluster randomization would be to avoid obtaining individual consent. Indeed, participants in cluster randomized trials have to be protected as in any type of trial design. Participants may be people from whom data are collected, but they may also be people who are intervened upon, and this includes both patients and physicians (for example, physicians receiving training interventions). Consent should be sought as soon as possible, although there may exist situations where participants may consent only for data collection, not for being exposed to the intervention (because, for instance, they cannot opt-out). There may even be situations where participants are not able to consent at all. In this latter situation a waiver of consent must be granted by a research ethics committee.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Université de Tours, Université de Nantes, INSERM, SPHERE U1246, Tours, France; INSERM CIC1415, CHRU de Tours, Tours, France. Electronic address: bruno.giraudeau@univ-tours.fr.
- Departments of Medicine, Epidemiology & Biostatistics, and Philosophy, Western University, 1151 Richmond Street, London, ON N6A 5B7, Canada.
- Centre for Primary Care and Public Health, Queen Mary University of London, 58 Turner Street, London, E1 2AB, UK.
- Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
- Clinical Epidemiology Program, Ottawa Hospital Research Institute, The Ottawa Hospital, Civic Campus, 1053 Carling Avenue, Ottawa, ON K1Y 4E9, Canada; School of Epidemiology and Public Health, University of Ottawa, Otta…
Zitieren
APA
Giraudeau, B., Weijer, C., Eldridge, S. M., Hemming, K., & Taljaard, M. (2024). Why and when should we cluster randomize?. Journal of Epidemiology and Population Health. https://doi.org/10.1016/j.jeph.2024.202197
Vancouver
Giraudeau B, Weijer C, Eldridge SM, Hemming K, Taljaard M. Why and when should we cluster randomize?. Journal of Epidemiology and Population Health. 2024. doi:10.1016/j.jeph.2024.202197
BibTeX
@article{Giraudeau2024,
author = {Giraudeau, Bruno and Weijer, Charles and Eldridge, Sandra M and Hemming, Karla and Taljaard, Monica},
title = {Why and when should we cluster randomize?},
journal = {Journal of Epidemiology and Population Health},
year = {2024},
doi = {10.1016/j.jeph.2024.202197}
}
EUVIMED